Exercise capacity, left ventricular hypertrophy and mortality in individuals with type 2 diabetes mellitus

被引：0
|
作者：
Kokkinos, P. [1 ]
Faselis, C. [1 ]
Nylen, E. [1 ]
Manolis, A. [1 ]
Pittaras, A. [1 ]
Doumas, A. [1 ]
Kokkinos, J. P. [1 ]
Kyritsi, F. [1 ]
Papademetriou, V. [1 ]
机构：
[1] Vet Affairs Med Ctr, Washington, DC 20422 USA
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [21] Patients with type 2 diabetes mellitus have an exaggerated brachial and central blood pressure response to exercise: Relation to left ventricular hypertrophy
    Sharman, J. E.
    Scott, J. A.
    Coombes, J. S.
    Prins, J. B.
    Leano, R.
    Marwick, T. H.
    HYPERTENSION, 2007, 49 (06) : 1476 - 1477
  • [22] Left ventricular hypertrophy predicts the decline of glomerular filtration rate in patients with type 2 diabetes mellitus
    Song, Haiying
    Hu, Haofei
    Liao, Dehan
    Wei, Jinghong
    Wei, Cuimei
    Liao, Fupeng
    Zhou, Wenxiong
    Mo, Zihe
    Jiang, Shilun
    Ruan, Xiongzhong
    He, Yongcheng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (11) : 2049 - 2059
  • [23] Left ventricular hypertrophy predicts the decline of glomerular filtration rate in patients with type 2 diabetes mellitus
    Haiying Song
    Haofei Hu
    Dehan Liao
    Jinghong Wei
    Cuimei Wei
    Fupeng Liao
    Wenxiong Zhou
    Zihe Mo
    Shilun Jiang
    Xiongzhong Ruan
    Yongcheng He
    International Urology and Nephrology, 2018, 50 : 2049 - 2059
  • [24] Association between metabolic visceral fat score and left ventricular hypertrophy in individuals with type 2 diabetes
    Wang, Lu
    Liu, Simo
    Ke, Jing
    Cao, Bin
    Wang, Di
    Zhao, Qianqian
    Gong, Haolin
    Fang, Yuan
    Zheng, Zhaohui
    Yu, Caiguo
    Wu, Nannan
    Ma, Yan
    Yu, Ke
    Yang, Longyan
    Zhao, Dong
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [25] Renal involvement and left ventricular hypertrophy are novel risk factors for morbidity and mortality in diabetes mellitus
    Boner, Geoffrey
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (05) : 425 - 429
  • [26] Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy
    Szwejkowski, Benjamin R.
    Gandy, Stephen J.
    Rekhraj, Sushma
    Houston, John G.
    Lang, Chim C.
    Morris, Andrew D.
    George, Jacob
    Struthers, Allan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (24) : 2284 - 2293
  • [27] Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy
    Dihoum, Adel
    Brown, Alexander J. M.
    McCrimmon, Rory J.
    Lang, Chim C.
    Mordi, Ify R.
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [28] ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE 2 DIABETES AND LEFT VENTRICULAR HYPERTROPHY
    Szwejkowski, B. R. S.
    Gandy, S. G.
    Rekhraj, S. R.
    Houston, G. H.
    Lang, C. C. L.
    George, J. G.
    Morris, A. D. M.
    Struthers, A. D. S.
    HEART, 2013, 99 : A93 - A93
  • [29] Left ventricular function and exercise tolerance in patients with type II diabetes mellitus
    Irace, L
    Iarussi, D
    Guadagno, I
    De Rimini, ML
    Lucca, P
    Spadaro, P
    Romano, A
    Mansi, L
    Iacono, A
    CLINICAL CARDIOLOGY, 1998, 21 (08) : 567 - 571
  • [30] 4.25 EKG Left Ventricular Hypertrophy and Risk of Cardiovascular Events in Patients with Type 1 and Type 2 Diabetes Mellitus
    M. Salvetti
    M. L. Muiesan
    B. Stanga
    A. Cimino
    U. Valentini
    A. Paini
    E. Belotti
    L. Micheletti
    C. Aggiusti
    C. Agabiti Rosei
    V. Paderno
    E. Agabiti Rosei
    High Blood Pressure & Cardiovascular Prevention, 2007, 14 (3) : 145 - 145
12345